Table of Contents

company-logo

Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. was incorporated in 2021 and is headquartered in New York, New York.

Indaptus Therapeutics Dividend Announcement

• Indaptus Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Indaptus Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Indaptus Therapeutics Dividend History

Indaptus Therapeutics Dividend Yield

Indaptus Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Indaptus Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Indaptus Therapeutics Financial Ratios

P/E ratio-0.66
PEG ratio0.01
P/B ratio1.63
ROE-177.27%
Payout ratio0.00%
Current ratio3.42
Quick ratio3.42
Cash Ratio3.31

Indaptus Therapeutics Dividend FAQ

Does Indaptus Therapeutics stock pay dividends?
Indaptus Therapeutics does not currently pay dividends to its shareholders.
Has Indaptus Therapeutics ever paid a dividend?
No, Indaptus Therapeutics has no a history of paying dividends to its shareholders. Indaptus Therapeutics is not known for its dividend payments.
Why doesn't Indaptus Therapeutics pay dividends?
There are several potential reasons why Indaptus Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Indaptus Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Indaptus Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Indaptus Therapeutics a dividend aristocrat?
Indaptus Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Indaptus Therapeutics a dividend king?
Indaptus Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Indaptus Therapeutics a dividend stock?
No, Indaptus Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Indaptus Therapeutics stocks?
To buy Indaptus Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Indaptus Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.